Vaniqa: profile and news






Barrier Therapeutics Announces First Quarter 2006 Financial ...  May 2, 2006
...quarter of 2005. Current quarter revenues include sales of Solagé® in the US and Canada, and VANIQA® in Canada only. Total revenues ... - Market Wire (press release)

Barrier Therapeutics to Present at Bank of America 2006 Health ...  May 10, 2006
The Company also markets its Solagé® product in Canada, along with VANIQA® (elflornithine HCI) Cream 13.9%, for which it is the exclusive distributor in ... - Market Wire (press release)


Home | About | Cancers | Treatment | Medications
Copyright onconews.org 2005.
All Rights Reserved.
Google
 
Web onconews.org